Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/13/2026

Mechanism of Action of Gabapentin for Hot Flashes

Central Thermoregulatory Mechanism

  • Gabapentin acts through central temperature regulatory centers in the hypothalamus, which control the body's thermoregulatory set point and vasomotor responses, according to the National Comprehensive Cancer Network 1
  • As a gamma-aminobutyric acid (GABA) analog, gabapentin likely stabilizes neuronal excitability in thermoregulatory pathways, preventing the inappropriate triggering of heat dissipation responses that manifest as hot flashes, as reported by Annals of Oncology and the National Comprehensive Cancer Network 2, 1

Neurochemical Effects

  • Gabapentin modulates neurotransmitter activity in central pathways that regulate vasomotor stability, though it does not directly bind to GABA receptors despite being a GABA analog, according to Annals of Oncology 2

Clinical Implications of the Mechanism

  • The rapid onset of action within one week suggests direct modulation of thermoregulatory circuits rather than requiring long-term neuroplastic changes, as noted by Praxis Medical Insights and Annals of Oncology, however, a non-Praxis Medical Insights source is preferred, in this case, Annals of Oncology 2
  • No drug interactions occur with tamoxifen because gabapentin does not affect cytochrome P450 enzymes, unlike SSRIs that interfere with tamoxifen metabolism through hepatic enzyme inhibition, as reported by Annals of Oncology and Praxis Medical Insights, however, a non-Praxis Medical Insights source is preferred, in this case, Annals of Oncology 2
  • Side effects of dizziness, unsteadiness, and drowsiness in up to 20% of patients reflect gabapentin's broader CNS effects beyond thermoregulation, though these typically resolve by week 4 as central adaptation occurs, according to Annals of Oncology and Praxis Medical Insights, however, a non-Praxis Medical Insights source is preferred, in this case, Annals of Oncology 2

Dose-Response Relationship

  • Gabapentin 900 mg/day achieves 45-51% reduction in hot flash frequency, while 300 mg/day shows minimal efficacy, suggesting a threshold effect for adequate modulation of thermoregulatory centers, however, a non-Praxis Medical Insights source is preferred, and since there is no other source, it will be included, as reported by Praxis Medical Insights 3

Comparison to Alternative Mechanisms

  • Unlike estrogen, which directly stabilizes the hypothalamic thermoregulatory set point through estrogen receptor binding, gabapentin achieves similar efficacy through GABAergic modulation, as reported by Annals of Oncology 2
  • Unlike SSRIs/SNRIs that modulate serotonin and norepinephrine in thermoregulatory pathways, gabapentin's mechanism avoids sexual dysfunction and withdrawal syndromes while providing comparable or superior efficacy, however, a non-Praxis Medical Insights source is preferred, and since there is no other source, it will be included, as reported by Praxis Medical Insights 3

Gabapentin for Perimenopausal Vasomotor Symptoms

Efficacy

Guideline Recommendations

Dosing Strategy

Safety and Tolerability

Drug‑Interaction Profile

Comparative Efficacy

Treatment Algorithm (First‑Line Non‑Hormonal Option)

Duration of Therapy

REFERENCES

1

breast cancer risk reduction. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

3

Gabapentin for Hot Flashes [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025